LATEST
Insmed Soaring High with Positive Phase II Results for Non Cystic Fibrosis Bronchiectasis Drug, INS1007
2020-02-03
First Sanofi Designed Investigational Enzyme Replacement Therapy for ASMD Gets Green Signal in Phase II/III Trial
2020-01-31